title: [Choriocarcinoma].
abstract: Choriocarcinoma is a malignant neoplasm with it's origin in trophoblast. It can be found after every pregnancy, but specially after pregnancy complicated by mola hydatidosa (complication in 2-3% of all molas). The main biochemical marker, used in treatment and prognosis is hCG. There are different prognostic systems for choriocarcinoma: presence of metastases, level of hCG in urine and plasma, end of last pregnancy. Surgical and chemical treatment in used. Outcome is generally good and very good.
authors.affiliation: Katedry i Zakładu Patomorfologii A.M. w Lodzi.
authors.forename: A
authors.initials: A
authors.lastname: Wierzchniewska
authors.forename: H
authors.initials: H
authors.lastname: Romanowicz-Makowska
mesh_terms: D015415:Biomarkers / Q000032:analysis; D002822:Choriocarcinoma / Q000175:diagnosis* / Q000209:etiology / Q000556:secondary / Q000628:therapy*; D006063:Chorionic Gonadotropin / Q000032:analysis; D005260:Female; D006801:Humans; D011247:Pregnancy; D011379:Prognosis; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
chemical_list: D015415:Biomarkers; D006063:Chorionic Gonadotropin
vernacular_title: Kosmówczak.